Thursday, May 31, 2012

Reply to an Answer

In response to:

Metastatic disease to the bone is a bad prognostic event and implies advanced prostate cancer. Complete androgen blockade (an LHRH agent as well as an anti-androgen such as Casodex) is needed to best control the disease. Unfortunately, over time patients with advanced disease tend to stop responding to these therapies. At that time the PSA will start to rise and therapy will be changed. Due to your advanced disease and relatively young age, it my be a reasonable approach to look into clinical research trials that are ongoing which may offer other suitable alternatives.

Subject:

Comment:

SIGN IN | REGISTER NOW

Create an account with HealthCentral. (Why?)

WHY REGISTER?

Connect with a supportive community
Get answers from Experts and health professionals
Save and Share your favorite articles and blogs

DISPLAY NAME

EMAIL ADDRESS

PASSWORD

By submitting, I agree to Remedy Health Media's terms and conditions.

Cancel »

Or, sign in with Facebook

You can register using your
Facebook account. Learn more »

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media